Macrophages are the most numerous leukocytes throughout the animal kingdom. Tissue macrophages are seeded by progenitor cells from the fetal yolk sac [9, 10] , can locally self-renew [11] and are also replenished by bone marrow-derived monocytes [12] . Necessary residents in virtually all tissues, macrophages (or macrophagelike cells) provide support and repair from cellular senescence and injury. Their location in the tissues also allows them to be rapid and critical responders to infections [3, [13] [14] [15] [16] . Evidence is abundant. A genetic lack of macrophages is fatal in humans (or other vertebrates) even prior to birth [17, 18] . Animals treated with drugs or that lack macrophage growth factors (e.g. CSFs) experience a reduction in macrophages and exhibit severe spontaneous pathology [17] [18] [19] [20] . Other innate cells also evolved in higher animals (e.g. neutrophils) to importantly aid macrophages in the elimination of pathogens [21] . For example, neutrophil-deficient humans or mice (e.g. after bone marrow transplantation) succumb to lethal infections [22] . Despite the abundance of macrophages, their location and their necessity for life, they have been chiefly viewed as supporting T cell and antibody responses in humans (and other vertebrates). This view of immunology had it backward [23, 24] . Adaptive immunity is a secondary host defense that developed in vertebrates to complement innate immunity. Evidence for this comes from analyses of the evolution of immune systems and the need for the rapid innate killing of pathogens that adaptive immunity cannot provide.
The Evolution of Immune Systems
Most animals do not possess T or B cells, yet they survive in a sea of pathogens. Earthworms, clams, etc. filter contaminated material all day without harmful infections [1, 2] , and some lower animals live for over 100 years. So, what protects most of the animal kingdom? Macrophages. First, tissue macrophages are essential for the health of specialized parenchymal and stromal cells by routinely maintaining tissue integrity through the repair or replacement of cells or matrices lost through senescence or following wounding. They are able to do this because they produce a variety of growth factors and enzymes that most tissue cells cannot [16, 17] . Second, macrophages also have a unique metabolic machinery (sometimes referred to as plasticity) that allows them to rapidly switch from their routine M2 'heal' mode to an M1 'inhibit' mode to kill pathogens, virus-infected cells or cancer [4, [25] [26] [27] .
Rapid Pathogen Elimination
Why is speedy killing necessary for animal defense? Two words: prokaryotic proliferation. For example, one bacterium can multiply to 8 × 10 16 in 4 days (the mass of a human), whereas one white cell can become only eight cells. This colossal prokaryotic advantage requires a rapid killing system. 'I feel the need for speed' (fighter pilot Tom Cruise in the movie 'Top Gun' -1986) properly describes what hosts require of macrophages. Macrophages found in all animals are able to ingest and kill infectious agents within hours, using a variety of reactive oxygen and nitrogen species [28] [29] [30] . Up through evolution, from around fishes onward, macrophages acquired the ability to produce signals that call other rapid innate killer cells to the site of infection, such as neutrophils, natural killer (NK) cells and innate lymphoid cells [1] . Direct evidence that rapid innate killing is important is indicated by studies on the lung that show pathogens proliferating out of control within a few days unless they are killed by innate responses [31] . Therefore, mathematical considerations (somehow overlooked) and animal studies, have actually made it clear that clonal proliferation of specific lymphocytes (adaptive immunity) is too slow to be a primary host defense (reviewed in [3] ).
Why Adaptive Immunity?
If most animals are protected from pathogens by macrophages/innate immunity alone, why did T cell and B cells develop in vertebrates? Three reasons: specificity, memory and the development of a vascular system.
Specificity
Innate immunity has limitations. Innate responses do have some specificity in recognizing pathogens [32, 33] ; however, the effector molecules produced kill nonspecifically. For example, macrophages produce nitric oxide (NO), a gas that freely diffuses in all directions, killing whatever is nearby including the macrophages themselves [34] [35] [36] [37] . Therefore, whenever innate immunity kills, it also causes collateral damage to normal tissue; that 'infected wounds do not heal', illustrates this phenomenon [38] . CD8+ T cells, in contrast, can specifically recognize a target cell, and deliver effector molecules directly without damage to themselves or surrounding cells [39] . Evidence suggests that T cells evolved from 'natural killer'-type lymphocytes with limited recognition specificity but specificity in killing [1] . CD4+ T cells can stimulate B cells that, like T cells, possess specificity in recognition and in killing [17, 40] . In addition, B cells can provide enhanced systemic protection by becoming plasma cells that produce antibodies able to penetrate areas that T cells cannot (e.g. mucosal surfaces) as well as efficiently neutralize toxins and certain pathogens.
Memory
Exposure of T or B cells to an antigen can result in a 100-fold or greater increase in their frequency [41] . Such memory can be long-lived, and accelerates specific responses upon reexposure to the same antigen, lessening the proliferative advantage of pathogens mentioned earlier. Memory has been thought of as the province of T cells. However, recent results suggest that the frequency of NK cells with selected specificities can also increase [42] [43] [44] .
The Vascular System
The third reason that specific T and B cells appeared in higher animals seems the most important. There was an evolutionary advantage to having separate organsnotably, a brain. Such separated organs require a centralized pumping organ and vasculature to distribute oxygen, nutrients and hormones. However, this vascular delivery system opened up portals all over the body where pathogens could enter, and then rapidly spread. This fact, combined with the colossal proliferative advantage of prokaryotes, created strong evolutionary pressure for a better-equipped immune system [3] .
Therefore, in parallel with the development of a vasculature, a separate 'lymph' system evolved to filter pathogens away from the vasculature and into specialized lymph organs containing specific T and B cells. Such sequestration allowed the efficient stimulation of lymphocytes in locales where this was required. Thus, the new adaptive system provided a secondary layer of specific memory-based defense for the vascular system and organs of higher animals.
Like nonspecific killing by innate cells, adaptive immunity brought with it some disadvantages as well. T and B cells use a recombination of genetic elements and somatic mutation to produce enormous receptor diversity. In doing so, some T cells and antibodies that attack the host are inadvertently and routinely produced. Hosts that fail to control these 'rogue' elements suffer uncontrollable autoimmunity [45] . In immunity, necessity begets complexity.
Innate Immunity Controls Adaptive Immunity
Immunology Had It Backward In order to understand adaptive immunity, it is necessary to appreciate that, although it provides certain important survival advantages, this 'new' system relies on innate immunity for initiation and direction. Macrophages recognize antigens (pathogens) directly [32, 46, 47] . T cells do not. T cells require direct interaction with macrophages (or dendritic cells 1 ) to proliferate [48, 49] . Furthermore, macrophages instruct T cells as to what type of response to make. Specifically, analyses of mouse strains revealed that resistance (C57Bl/6) or susceptibility (Balb/c) to Leishmania could largely be explained by differences in their macrophages rather than T cells [4] . Macrophages in M1 inhibit mode direct T cells to produce Th1-like cytokines (e.g. IFN-γ) that stimulate specific cytolytic T cells and activate more M1 macrophages ( fig. 1 a) [50] [51] [52] . In contrast, macrophages in the M2/ heal mode stimulate T cells to produce Th2-like cytokines (e.g. IL-4 and TGF-β) that cause B cell proliferation and antibody production [25, 53] and further amplify M2 responses. In particular, M2-amplified activity stimulates fibrosis and matrix production that can wall off pathogens or inert materials via a 'foreign body' reaction [4, 54] . Thus, macrophages actually use T cells as the 'middle man' to further amplify M1 or M2 dominant responses. Of course, infectious or other threats come in many varieties and occur at many sites in a host. In turn, macrophage-directed adaptive immunity is often a mixture of M1/Th1 and M2/Th2 responses [16, 24, 55] .
The most important point here is that these recent findings with macrophages [4] and dendritic cells [58] indicate that a long-held belief -that T cells direct the type of immune response by 'activating' or 'alternatively activating' macrophages -is backward [23, 24, [59] [60] [61] [62] . Instead, macrophage responses are independent of T cells, and also direct Th1 and Th2 responses, as will be described later. Hence, macrophages were renamed M1 and M2 to highlight that innate immunity is the central controlling element in immune systems [4] .
M1/M2 Macrophages and Other 'Subsets'
Some investigators have described other 'subsets' of macrophages [5, 7, 63, 64] . This has created some confusion. It is useful to clarify that M1 and M2 were originally defined by their preferential expression of inducible NO synthase (iNOS) or arginase, respectively, and that they both direct T cell responses [4] . Another macrophage subset is 'alternatively activated' macrophages, a term that arose by adding the T cell cytokine IL-4 to macrophages in vitro [8] . However, subsequent evidence obtained by these investigators revealed that 'alternatively activated' macrophages resemble M2 macrophages very closely [65] . The observation that M2 activity (e.g. arginase) is strongly upregulated in sterile wounds and growing tumors where there are only a few T cells and no IL-4 provided evidence that 'alternatively activated' macrophages are not a distinct subset [66] .
The perception that macrophages require T cells to become functional resulted in investigators adding various T cell cytokines and other factors to macrophages in vitro, observing differences in in vitro assays and creating subsets such as M2 a, b and c, type II or regulatory macrophages [5-7, 63, 64, 67, 68] . What was overlooked, though, is that the M1-type NO/inhibit activity expressed by macrophages in vitro, often called 'suppressor' activity [69] , also decreases their viability in vitro [35] . In turn, if such M1-type cells perish (leaving proportionally more M2-type cells), assaying whole populations can create the impression that the M1-type cells use 'plasticity' to convert back to M2-type cells or that so-called 'regulatory' macrophages are involved [5, 6, 60, 70] .
We proposed that while M2-type macrophages can convert to the M1 type, the M1 is normally an end-stage 'killer' cell [3] . In this scenario, M1-type macrophages often die and get replaced by replicating tissue macrophages or monocyte-derived macrophages. One way to investigate the intraconvertibility of M1 or M2 macrophages would be to use formal lineage-tracking studies using mice expressing Cre recombinase under the iNOS (M1) and arginase (M2) promoters, respectively. Regardless of the directionality of 'plasticity', M1/inhibit and M2/heal responses are important responses in vivo [3, 56, 58] . In addition, all 'inflammation' is constantly evolving. In turn, analyses of whole cell populations can create illusory heterogeneity, particularly in vitro. In this regard, the other macrophage subsets described above have not been shown to have any unique distinguishing functions. Therefore, the most straightforward (and testable) explanation for observations of subsets is that these are varying mixtures of M1-and M2-type macrophages. Recent transcriptome analyses of macrophages present at different sites (e.g. the lung or peritoneal cavity) have revealed tissue-specific variations in the balance of M1-and M2-type responses [71, 72] .
Varying mixtures of M1-and M2-type macrophages in vitro (and in vivo) led some authors to incorrectly attribute certain products to M1 or M2 responses and created confusion [63, 73] . It simplifies matters to think of M1 products as those that initiate (directly and indirectly) 'inhibit' responses, and M2 products as those that heal damage (from M1 or injury) and are able to stimulate antibody production. Products closely associated with M1/ inhibit responses are iNOS/NO production, increased IL-12 production, increased MHC class II expression and the chemokines IL-8 and CCL2 ( fig. 1 b) . M2/heal responses, in contrast, are associated with the production of arginase/ornithine, EGF, VEGF and TGF-β, and mannose receptor expression. Other products, like IL-6 and TNF or IL-1 and IL-10, are only loosely associated with M1 or M2 responses, respectively. However, these cytokines have been observed in both M1-and M2-type responses, as have NADPH oxidases, and various matrix-remodeling metalloproteinases [4, 28, [74] [75] [76] . Such molecules indicate the presence of macrophages, but should not be strictly ascribed to M1/inhibit or M2/heal activity as has been done [7, 63] . In this regard, it is useful to appreciate that the simple presence of macrophages creates 'inflammation' -be it the M1/inhibit or the M2/heal type. Both types can be painful. It is more informative to describe the specific type of inflammation. Finally, phagocytosis is a general property of macrophages, but not a reliable predictor of M1/inhibit-or M2/heal-type responses.
Summary
The ever-changing physiological landscape of protecting complex vertebrate anatomies from different infectious and noninfectious threats creates a constantly changing cornucopia of macrophage responses. There is necessary plasticity [77] . But, finally, for hosts to survive, macrophages need to function in distinct ways. Macrophage functions usefully distill down to varying mixtures of M1/inhibit and M2/heal responses [3] . Through these innate responses, macrophages are the central controlling element for tissue integrity and host defense, whether acting alone (in most animals) or also directing adaptive responses in vertebrates ( fig. 2 ) . The second part of this perspective will describe how macrophages carry out their necessary activities by describing the four basic functions of these unique, multitalented cells. 10 macrophages in humans, i.e. they are the leukocytes in greatest abundance. Second, each of these macrophages lives in a slightly different environment, defined by its host organ and tissue location. Third, to perform different activities, macrophages possess a unique and versatile metabolic machinery [4, 78] . With them all adapting to protect the host in different ways (and at different times), it is natural that when one examines the macrophage populations as a whole, they display heterogeneity in their functions. Plasticity is sometimes used to describe this dynamic circumstance [77] . However, as mentioned earlier, what matters most to a host is the underlying functions of macrophages and how these affect health. There are four such functions: sample, heal, inhibit and present, referred to as the 'SHIP' functions.
The Macrophage 'SHIP'
A macrophage is akin to a warship anchored in a harbor watching over a town (pun intended). Both monitor their environs. Ships use radar. Macrophages sample surrounding tissues where they reside. Most of the signals they receive are benign, perhaps a fishing boat. A macrophage routinely detects senescent cells and debris and, using its 'heal' mode, M2 [4] , it ingests and digests these materials and, via the production of growth factors, helps to restore lost cells and intercellular matrices [3, 16] . A critical function of a warship for the harbor town, or a macrophage for the host, is protection. A ship possesses guns to combat enemy ships. A macrophage can switch to the 'inhibit' mode, called M1, and produce chemicals to kill enemy pathogens. The 'guns' of a ship or a macrophage can kill friend or foe, so knowing when to use them is critical. Macrophages know this through sampling, and possess the unique ability to change from the heal mode to the inhibit mode, thanks to a remarkably simple metabolic switch involving arginine. Normally, macrophages metabolize arginine to the heal-molecule, ornithine. However, they can rapidly switch to metabolizing arginine to the inhibit-molecule, NO [4] .
Most animals are protected by the three macrophage functions sample, heal or inhibit. However, humans and other vertebrates developed a fourth macrophage function, the ability to 'present (antigen)' [48, 49] . As discussed earlier, this 'present' function directs T and B cells into making more specific, diverse and protective responses than can be provided by innate immunity. We discuss the four SHIP macrophage functions in more detail below.
SHIP 1: Sample
The first function of macrophages is to sample. The earliest method of sampling, phagocytosis, was observed by Metchnikoff over 100 years ago in sea urchins; he logically named macrophages 'big eaters' [79] . Eating/engulfing is a primordial function in animals, with macrophage-like cells being found throughout the animal kingdom. An amoeba is a free-living 'macrophage' [1] . Macrophages are now known to be strategically positioned in virtually all the tissues in humans (and other species), in order to carry out daily phagocytic removal of debris or effete or dead cells [3, 16] . Macrophages in this heal mode are called M2 [4] .
While phagocytosis remains a signature method for identifying macrophages, other leukocytes, e.g. neutrophils, also phagocytize. Macrophages can do much more than eat and digest, a daily duty. Unique among leukocytes, macrophages possess a variety of sampling receptors to analyze their surroundings and distinguish types of threats to an organism. Two basic types of receptors have been described: those that recognize injury and those that that recognize infection, i.e. damage-and pathogen-associated molecular patterns (DAMPs and PAMPs), respectively. DAMP and PAMP receptors are found on the surface and interior of macrophages [46, 47, 80] . DAMPs come mainly from distressed or dead host cells, and include molecules like heat-shock proteins, ATP, hypoxia or changes in osmolality or pH [80, 81] . The macrophage response to PAMPs in animals involves the recognition of proteins, sugars, lipids or nucleic acids unique to pathogens. Phagocytosis may be involved, but is not necessary for these responses. From sampling, macrophages can rapidly switch from the M2/heal mode to the M1/inhibit mode described earlier. The inhibit reaction displayed by macrophages upon sampling these signals in lower animals is called a 'stress' response. It can occur in minutes, causing the production of reactive oxygen species like superoxide from preformed NADPH oxidases, called 'NOX' enzymes [82] .
Later in evolution, macrophages added other innate inhibit pathways such as NO production [1, 34, 83] to supplement the stress response. There are similar receptors in plants that recognize DAMPs or PAMPs, highlighting the survival importance of these inhibit reactions in nature [30] . About 95% of all animal species possess only innate sampling and recognition systems [1, 2] , and yet, they are as 'happy as clams' (healthy). How do most animals survive with only macrophages (and other innate leukocytes)? By modulation of the heal response and the inhibit response.
SHIP 2 and 3: Heal or Inhibit
Sampling the environment can cause macrophages to make one of Nature's most important health decisions: whether to remain in routine heal mode or to switch to inhibit mode. In this connection, the stress response described above explained how primitive macrophages inhibit by means of superoxide. However, superoxide or its reactive oxygen species derivatives, e.g. H 2 O 2 , could not fully explain the inhibit response observed in macrophages in higher animals. They possessed an unknown and powerful inhibit molecule. What was also stupefying was how one cell could seemingly exhibit the completely opposite responses of heal or inhibit. This biochemical conundrum came down to one amino acid: arginine. In the 1970s and 1980s, it was observed that arginine is uniquely depleted at sites of inflammation, like wounds [25, 83, 84] . Macrophages were shown to be responsible by actively metabolizing arginine with arginase into ornithine and urea [25, 78] . There is a very important reason for this: macrophage production of ornithine is required for many repair processes because it is a precursor of the polyamines required for cell proliferation and of collagen for extracellular matrix construction [25] . So, the biochemical basis of the macrophage heal response was elucidated first.
The other side of the macrophage coin -how they inhibit in higher animals -was discovered in the late 1980s by Hibbs et al. [34, 83] . Remarkably, their studies showed that, instead of metabolizing arginine to ornithine to heal, macrophages can metabolize arginine by means of the iNOS enzyme to the inhibit molecule NO (a gas) and citrulline (a nonencoded amino acid). Macrophages are the main cells in the body with this arginine 'fork in the road' switching capacity [25] . These two enzymes and products are found in macrophages in all higher animals including humans [85] [86] [87] . The importance of this switch mechanism is indicated by the fact that the production of ornithine or NO by macrophages is closely linked to the production of other heal or inhibit molecules, as mentioned earlier ( fig. 1 ) . The heal mode is associated with the production of several growth/repair factors like EGF, VEGF and TGF-β as well as the expression of the mannose receptor. In contrast, the inhibit mode is associated with molecules that attract other innate killer cells like IL-8 (neutrophils) or CCL2 (monocytes) [16, 88] , with increased MHC class II expression to present antigens to CD4 T cells as well as production of IL-12 and IL-23 which polarize T cells to make Th1-like and Th17-like cytokines and stimulate killer responses in other leukocytes.
So, how does a macrophage decide to heal a problem or inhibit a problem? It was thought that T cell products were required for macrophages to be 'activated' to be able to exhibit heal or inhibit modes [23, 24, 59] . This longheld notion has recently been corrected, as we have already discussed. Again, the heal and inhibit responses of macrophages are both found in simple animals lacking T or B cells [1] . Even more important to our understanding of human immunity, these responses occur in T cell-deficient vertebrates [4] . They are now called M1 and M2 because they also direct the responses of T cells, e.g. Th1, Th2, Th17 and Treg cells. Unshackling innate immunity from adaptive immunity is allowing new perspectives on immunity as a whole.
Macrophages in the M2/heal mode are not 'alternatively activated' for their duties of clearing up the dead cells and debris that accumulate from day to day or helping to replace lost tissue and matrices. Since T cells are not necessary for macrophage heal responses, the question that arises is: Does a macrophage M2/heal response require 'immunologic' signals at all? Or, is this simply the response observed in the absence of signals to inhibit damage or pathogens? Stated otherwise, M2/heal is the default mode of macrophages [3] . Such cells are not in an 'off' mode requiring a signal to be turned on, but are functional cells. It may be useful to view an M2 macrophage as a parked car full of people happily talking. The fuel and turn signals (the cytokines) are not necessary, as purported [7, 63] . Of course, innate or nonimmune tissue signals like TGF-β could be required to maintain macrophages in the M2 mode or to amplify M2 activity.
It does appear that the switch from M2/heal to M1/ inhibit mode requires exogenous activation by DAMPs or PAMPs. But, like the M2 mode, the M1 mode does not require T cells [4] . It is important, therefore, to determine the innate or other non-T cell signals that modulate the relative levels of M1-and M2-type responses. For M2, the known candidates include: NK cell (innate)-derived IL-4, TGF-β, IL-10, some of the DAMP receptors (including scavenger receptors) and perhaps the absence of signals that stimulate M1 responses. For M1, the known stimuli include: PAMPs that bind to families such as the Toll-like, NOD-like and RIG-I-like receptors and the C-type lectins [32, 46, [89] [90] [91] [92] [93] .
With hindsight, it is easy to see how macrophages came to be viewed as being directed by T cells. It would appear that the Th1/Th2 paradigm arose in fair measure from equating immune phenomena observed in vitro with how the immune system operates. However, 'in vivo veritas' or 'the tail does not wag the dog' [3] . Earlier, we saw the danger of relying on in vitro cultures to make conclusions about macrophage 'subsets' and products. In turn, in order to go forward, it seems prudent to rely on results that have demonstrable physiological relevance for defining how M2/heal and M1/inhibit responses are regulated. Such information is also useful for understanding how the fourth innate SHIP function, i.e. -presenting antigen, determines whether/ which T cell responses occur in humans (and other vertebrates).
SHIP 4: Present (Antigen)
The fourth macrophage SHIP function, i.e. present (antigen), like any biological system, developed because it provided an evolutionary advantage. This function, evident in the first jawed vertebrates, fishes, appeared at the same time as the MHC complex [1] . Evolutionary pressure must have been strong because the parallel development of a separate lymphatic system and T and B cells in vertebrates created a more complicated immune system. As discussed, the separate vasculature of vertebrates required the superior protection provided by lymphatics, immunological memory and antibodies. Macrophages presenting antigen to T cells (in combination with self MHC class I or II antigens) is a function that seems to have evolved to allow them to direct the T and B cells to a specific response best-suited for protection against different pathogens and toxins, and to avoid responses that work against the host. Macrophages recognize many pathogens through PAMP receptors that switch the resident tissue (or lymphatic) M2/heal-type macrophages to M1/inhibit-type macrophages. This switch is accompanied by the upregulation of class II MHC molecules and the production of cytokines like IL-12 and IL-23 [3] , which help them present antigen to T cells and shepherd these into producing cytokines that convert more M2 macrophages into M1 macrophages [4] . If, for example, the pathogen is intracellular, this heightened M1 response promotes efficient killing. M1-type macrophages also serve to locally amplify responses through chemokines like CCL2 which attract monocytes from the vasculature that can rapidly become M1 macrophages.
On the other hand, some pathogens do not activate M2 macrophages to become M1 macrophages, either because of the type of PAMP receptor they stimulate or because some pathogens actively suppress the switch from the heal to the inhibit mode [16, 25, [94] [95] [96] . To combat this prokaryotic advantage, vertebrate T cells have developed the ability to recognize M2-type macrophages that express foreign antigens and to respond with the production of a very different set of cytokines [4] , like IL-4, IL-13 and TGF-β that stimulate B cells to become antibody-producing plasma cells [40, 53, 97] and suppress the M2 to M1 switch. In addition, specific antibody-binding to a target can restrict collateral damage of macrophages by focusing them (through Fc and complement receptors) to where the pathogens are. Finally, it is likely that many pathogens stimulate mixes of M1-and M2-type responses, depending on where the pathogen resides and the severity of the infection [87, 98] .
Macrophages thus evolved the ability to present antigen in different ways for using T cells to amplify the particular types of adaptive immunity most suitable for the elimination of different pathogens. The SHIP functions of macrophages are summarized in figure 3 .
Conclusion
Macrophages/innate immunity act alone in all animals, using the sample, heal or inhibit functions to provide primary host defense and maintain tissue homeosta- sis. In vertebrates, macrophages also use the present (antigen) function to direct adaptive immunity in different ways in order to provide another layer of protection. The recognition of the importance of macrophages, their basic functions and how they are regulated is critical for designing new immunological strategies for better health. This is particularly so for many modern diseases, such as cancer and atherosclerosis, which may not express 'foreign' antigens. Macrophages are the chicken and the egg of immunity.
